Myeloma Master Class

This educational series is designed to provide insights and guidance
on the critical and challenging issues in multiple myeloma.
More information coming soon

MYSummit Myeloma Conference October 7-9, 2021

MYELOMA360 is pleased to announce our first annual MYSummit Conference
October 7-9, 2021 in Edinburgh, UK

Ask the Experts

You have questions. Our Expert Panel responds.

Myeloma News

Keep up to date on the latest multiple myeloma news and information.

News

FDA Lifts Clinical Hold on MELANI-01 Study Evaluating UCARTCS1

FDA Lifts Clinical Hold on MELANI-01 Study Evaluating UCARTCS1

Cellectis announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Phase 1 MELANI-01 trial evaluating the UCARTCS1 product candidate for the treatment of patients with relapsed or refractory multiple myeloma (MM). Cellectis worked...

read more

Featured Content

Join Our Community

By joining the MYELOMA360 community, you will receive regular updates with news, information, insights and expert opinions. 
Of course, you can opt out at any time.